BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen D, Huang Z, Ning Y, Lou C. Knockdown of LINC02471 Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375. Cancer Manag Res 2020;12:8757-71. [PMID: 33061573 DOI: 10.2147/CMAR.S243767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhu X, Wang X, Gong Y, Deng J. E-cadherin on epithelial-mesenchymal transition in thyroid cancer. Cancer Cell Int 2021;21:695. [PMID: 34930256 DOI: 10.1186/s12935-021-02344-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Cui T, Guo J, Sun Z. A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability. Expert Rev Mol Diagn 2021;:1-10. [PMID: 34871123 DOI: 10.1080/14737159.2021.1979960] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Song J, Zhang S, Sun Y, Gu J, Ye Z, Sun X, Tang Q. A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer. J Oncol 2021;2021:4338838. [PMID: 34594376 DOI: 10.1155/2021/4338838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wei J, Lu Y, Wang R, Xu X, Liu Q, He S, Pan H, Liu X, Yuan B, Ding Y, Zhang J. MicroRNA-375: potential cancer suppressor and therapeutic drug. Biosci Rep 2021;41:BSR20211494. [PMID: 34494089 DOI: 10.1042/BSR20211494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang Y, Yan K, Wang L, Bi J. Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology. BMC Cancer 2021;21:727. [PMID: 34167490 DOI: 10.1186/s12885-021-08356-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Yang H, Xiong X, Li H. Development and Interpretation of a Genomic Instability Derived lncRNAs Based Risk Signature as a Predictor of Prognosis for Clear Cell Renal Cell Carcinoma Patients. Front Oncol 2021;11:678253. [PMID: 34094983 DOI: 10.3389/fonc.2021.678253] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]